{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:41:47Z","timestamp":1792431707306,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["3UG1DA015831"],"award-info":[{"award-number":["3UG1DA015831"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jemermed.2023.06.007","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T12:17:08Z","timestamp":1687263428000},"page":"e357-e365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["URINE TOXICOLOGY PROFILES OF EMERGENCY DEPARTMENT PATIENTS WITH UNTREATED OPIOID USE DISORDER: A MULTI-SITE VIEW"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7276-0549","authenticated-orcid":false,"given":"Ethan","family":"Cowan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanmarie","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Dziura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Jennifer","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Hawk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Herring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manali","family":"Phadke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"D'Onofrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2023.06.007_bib0001","series-title":"Provisional Drug Overdose Death Counts","author":"Ahmad","year":"2021"},{"issue":"50","key":"10.1016\/j.jemermed.2023.06.007_bib0002","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.15585\/mmwr.mm7050e3","article-title":"Trends in and characteristics of drug overdose deaths involving illicitly manufactured fentanyls\u2014United States, 2019\u20132020","volume":"70","author":"O'Donnell","year":"2021","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"key":"10.1016\/j.jemermed.2023.06.007_bib0003","series-title":"The Future of Fentanyl and Other Synthetic Opioids","author":"Pardo","year":"2019"},{"key":"10.1016\/j.jemermed.2023.06.007_bib0004","unstructured":"NFLIS-Drug 2020 Annual Report. US Drug Enforcement Administration, Drug Enforcement Administration Diversion Control Division. Accessed XXXX. https:\/\/www.nflis.deadiversion.usdoj.gov\/nflisdata\/docs\/NFLISDrug2020AnnualReport.pdf."},{"key":"10.1016\/j.jemermed.2023.06.007_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108314","article-title":"Steep increases in fentanyl-related mortality west of the Mississippi River: recent evidence from county and state surveillance","volume":"216","author":"Shover","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jemermed.2023.06.007_bib0006","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department\u2013initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial","volume":"313","author":"D'Onofrio","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2023.06.007_bib0007","first-page":"357","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jemermed.2023.06.007_bib0008","article-title":"Has the treatment gap for opioid use disorder narrowed in the US?: a yearly assessment from 2010 to 2019 [published online ahead of print August 4","author":"Krawczyk","year":"2022","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jemermed.2023.06.007_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2021.106359","article-title":"The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED Innovation","volume":"104","author":"D'Onofrio","year":"2021","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jemermed.2023.06.007_bib0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.jemermed.2023.06.007_bib0011","article-title":"International Classification of Diseases, 10th Revision","year":"2023","journal-title":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.jemermed.2023.06.007_bib0012","unstructured":"Artigiani E, Hsu M, McCandlish D, Wish E., Methamphetamine: A Regional Drug Crisis. National Drug Early Warning System; 2018."},{"issue":"35","key":"10.1016\/j.jemermed.2023.06.007_bib0013","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.15585\/mmwr.mm6935a1","article-title":"Vital signs: characteristics of drug overdose deaths involving opioids and stimulants\u201424 states and the District of Columbia, January\u2013June 2019","volume":"69","author":"O'Donnell","year":"2020","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.jemermed.2023.06.007_bib0014","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/epirev\/mxaa011","article-title":"The evolving overdose epidemic: synthetic opioids and rising stimulant-related harms","volume":"42","author":"Jones","year":"2020","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.jemermed.2023.06.007_bib0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.23907\/2013.010","article-title":"National Association of Medical Examiners and American College of Medical Toxicology Expert Panel on Evaluating and Reporting Opioid Deaths. Recommendations for the investigation, diagnosis, and certification of deaths related to opioid drugs","volume":"3","author":"Davis","year":"2013","journal-title":"Acad Forensic Pathol"},{"key":"10.1016\/j.jemermed.2023.06.007_bib0016","article-title":"Only 5% of overdose patients tested for fentanyl, #1 killer of Americans 18-45","author":"Little","year":"2022","journal-title":"Epic Research"},{"key":"10.1016\/j.jemermed.2023.06.007_bib0017","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsat.2010.03.014","article-title":"Self-treatment: illicit buprenorphine use by opioid-dependent treatment seekers","volume":"39","author":"Schuman-Olivier","year":"2010","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.jemermed.2023.06.007_bib0018","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2018.09.007","article-title":"Understanding the use of diverted buprenorphine","volume":"193","author":"Cicero","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jemermed.2023.06.007_bib0019","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jsat.2019.07.005","article-title":"Buprenorphine in the United States: motives for abuse, misuse, and diversion","volume":"104","author":"Chilcoat","year":"2019","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.jemermed.2023.06.007_bib0020","article-title":"Transition from injecting opioids to smoking fentanyl in San Francisco","volume":"227","author":"Kral","year":"2021","journal-title":"California. Drug Alcohol Depend"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467923003566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467923003566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:51:29Z","timestamp":1760028689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467923003566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0736467923003566"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2023.06.007","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"URINE TOXICOLOGY PROFILES OF EMERGENCY DEPARTMENT PATIENTS WITH UNTREATED OPIOID USE DISORDER: A MULTI-SITE VIEW","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2023.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}